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ABSTRACT
Miyazaki, M., Itoh, H., Ambiru, S., Shimizu, H., Togawa,
A., Gohchi, E., Nakajima, N. and Suwa, T. (1996) Radical
surgery for advanced gallbladder carcinoma. British Journal
of Surgery; 83, 478 481.
Forty-four patients with advanced gallbladder carci-
noma (18 with stage pT3 and 26 with stage pT4 of the
Union Internacional Contra la Cancrum classifica-
tion) were aggressively managed by extended
heptatic resection in 33 patients, bile duct resection
in 28, pancreaticoduodenectomy in seven, gastro-
intestinal resection in eleven and portal vein resec-
tion and reconstruction in seven. Adjacent organ
involvement was classified as follows: type I,
hepatic involvement with or without gastrointest-
inal invasion (Ia, Ib); type II, bile duct involvement
with or without gastrointestinal invasion (IIa, IIb);
type III, hepatic and bile duct involvement with or
without gastrointestinal invasion (IIIa, IIIb); type
IV, gastrointestinal involvement without hepatic or
bile duct invasion. Fourteen of 15 patients with type
I tumours had a curative resection compared with
seven of 26 with type III lesions (P< 0.0001). The
surgical mortality rate was two of 15 patients with
type I tumours, seven of 26 with type III tumours
and nine of 44 for the whole group. The long-term
survival rate after curative resection was four and
two of 23 at 3 and 5 years respectively, significantly
better than two and none of 21 at I and 2 years after336 HPB INTERNATIONAL
non-curative resection (P<0.01). The survival rate
after curative resection for patients with type I
tumours was four and two of 14 at 3 and 5 years
respectively, significantly better than for other
types (P<0.05). This classification of advanced
gallbladder carcinoma according to involvement of
adjacent organs might be helpful in planning
surgery for this condition; in particular, type I
tumours should be treated by a radical surgical
procedure to achieve a favourable outcome.
Keywords: Pancreaticogastrostomy, pancreaticojejunostomy,
pancreaticoduodenectomy
PAPER DISCUSSION
Surgery for advanced gallbladder cancer re-
mains a controversial topic because of the poor
prognosis and lack of controlled studies. "Radi-
cal surgery for advanced gallbladder cancer"
presents the authors’ surgical experience with 44
patients who had advanced gallbladder cancer.
All 44 patients were at least a Nevin’s Stage III or
IV cancer. They were further subdivided by the
authors into four different types: 1. hepatic type,
2. biliary type, 3. hepatobiliary type and 4.
others. By using this subdivision, the operative
mortality of the procedures could be analyzed in
a more meaningful fashion. Of the 15 patients
with Type 1 tumors, two (13%) had a surgical
mortality and 14 (93%) had an attempt at
curative resection. In contrast, only 7 (27%) of
the 26 patients with Type III lesions had a
curative resection with 7 (27%) having a surgical
mortality. The only two patients of the whole
series of 44 patients that survived for more than
five years were in the Type 1 group.
The operative mortality for patients in both
groupswas poor. Overall for thewhole group, the
surgical mortality was 20%, and only 23 of the 44
patients had attempted curative resections (52%).
The long term survival rate, after curative
resection which was done in only 23 patients
(52%), was four patients at three years, and two
patients at five years, an 8.7% overall five year
survival. This report underscores the dismal
prognosis with gallbladder cancer where only
two out of 44 patients survived for five years.
Furthermore, it is not even noted if those two
patients are disease free. The authors are trying
to make a case for the fact that the two patients
who did survive had Type 1 tumors. This is a
14% five year survival for this type, but it still
remains dismal. More importantly, it is upset-
ting to note that even for the Type 1 tumors, the
survival and the mortality from the operation
are almost exactly equal numbers. For the Type
2 group, there is no five year survival and the
mortality is 26%.
Although the authors are trying to select the
patients who should have radical surgery, I
think that this paper points out that radical
surgery should not be done at all. When radical
surgery has a 30 day mortality that is greater
than the possible survival benefit, its usefulness
must be questioned. Especially in this period
of renewed efforts with new Phase 1 chemo-
therapy agents, it might be much more efficac-
ious for a patient to have a chance at a response
with chemotherapy rather than die from an
operation.
Furthermore, this study did not describe the
prognostic benefit of the lymph nodes status.
Since lymph node involvement is another sign of
advanced tumor, it might be interesting to know
if the patients who had longer survival had
positive lymph nodes or not. This is not men-
tioned in the text of the paper.
The literature on gallbladder surgery is
moderately sparse because of the lack of large
studies on this disease and because of the very
poor survival after surgery for this disease. One
of the largest U.S. studies of. gallbladder cancer
is a review from the Mayo Clinic of all the
patients treated surgically at that institution for
a 12 year period [1]. Of the 111 patients who had
surgery, 20% had a biopsy only and another 27%
had a palliative cholecystectomy and 20 patients
had radical resections with no mortality.
Although overall, there was no difference inHPB INTERNATIONAL 337
survival for the patients having the cholecys- the mean survival seems to be less than six
tectomy over the radical resection; this was not months, which is not that different than the 124
a randomized series and the patients in the day (four months) mean, survival for patients
cholecystectomy group were those with the with non-curative resections. These patients
more favorable disease stage. In the radical should not be offered surgical resection since
surgery group 3 patients with Nevin’s Stage 3, their mortality far exceeds the possible curative
and two with Nevin’s Stage 4 survived, and the surival benefits.
only patient in the group with Nevin’s Stage 2 Whether or not patients with the Type 1
survived. The conclusions we can make from disease, i.e. disease which extends into the liver
these kinds of studies are limited. Some patients or without intestinal involvement, should have
will benefit from radical resection, but it is not surgery is a very difficult question to answer
clear which ones. Mortality from radical surgery [4, 5]. It seems at first glance that with a
must, however, be low enough to equal the mortality of 8.7% and a five year survival of
possible benefit. 14%, the benefit is negligible. However, there
Currently it is believed that patients with may be a survival benefit for this group overall,
Nevin’s Stage 1 and in situ disease, that is a not a five year survival benefit, but a mean
disease that is limited to the mucosa, have a 60% survival benefit. Unfortunately, this cannot be
clLance of survival [2]. Whether those patients deduced from this report since the only in-
would do better with more radical operations formation on this is in Figure 3 which is
remains controversial. Patients with Nevin’s inaccurate since it shows the Type 1 patients
Stage 2 disease only have a survival of around having a 40% five year survival, which we know
20% [3]. One must keep in mind that Stage 2 is different than the text.
disease is a disease that is still in the wall of the In conclusion, the case for surgery in
gallbladder. Here again, the controversy over patients with gallbladder cancer very much
whether doing a more radical cholecystectomy remains an open issue. For patients with
which includes removal of the liver bed and earlier cancer, the question still is how radical
dissection of the periportal lymph nodes is should the surgery be. For patients with
unclear and no randomized prospective study advanced disease, the usefulness of surgery
has been done. seems minimal at best. All of the information
The present paper points out that in patients underscores the need for better treatments for
with disease that is beyond Stage 2, which is this type of cancer and a more multidisciplin-
the case for all of these patients, a chance of ary approach. Also, a multinational protocol to
cure is very minimal and surgery should be investigate treatments for gallbladder cancer
embarked upon only in very selected cases, could be very important for any improvements
Perhaps looking at the criteria that these in the future.
authors have delineated may offer some guide-
lines for the future. Patients with the Type 3
disease delineated by the authors, that is
disease involving both the liver and the extra-
hepatic bile ducts with or without intestinal References
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Mini-Incision Versus Laparoscopic
Cholecystectomy
ABSTRACT
Majeed, A. W., Troy, G., Nicholl, J. P., Smythe, A., Reed,
M. W. R., Stoddard, C. J., Peacock, J. and Johnson A. G.
(1996) Randomised, prospective, single-blind comparison of
laparoscopic versus small-incision cholecystectomy. The
Lancet; 347, 989 994.
Keywords: Laparoscopic cholecystectomy, mini-incision
cholecystectomy
PAPER DISCUSSION
Background: We report a prospective randomised
comparison between laparoscopic and small-incision
cholecystectomy in 200 patients which was designed
to eliminate bias for or against either technique.
Methods: Patients were randomised in the oper-
ating theatre and anaesthetic technique and
pain-control methods were standardised. Four
experienced surgeons did both types of procedure.
Identical wound dressings were applied in both
groups so that carers could be kept blind to the
type of operation.
Findings: There was no significant difference be-
tween the groups for age, sex, body mass index, and
American Society of Anaesthesiologists grade.
Laparoscopic cholecystectomy took significantly
longer than small-incision cholecystectomy (median
65 [range 27-140] min vs 40 [18-142] min, p<0.001).
The operating time included operative cholangio-
graphy which was attempted in all patients. We
found no significant difference between the groups
for hospital stay (postoperative nights in hospital,
median 3.0 [1-17] nights for laparoscopic vs 3.0
[1-14] nights for small-incision, p=0.74), time back
to work for employed persons (median 5.0 weeks vs
4.0 weeks; p=0.39), and time to full activity (median
3.0 weeks vs 3.0 weeks; p=0.15).
Interpretation: Laparoscopic cholecystectomy takes
longer to do than small-incision cholecystectomy
and does not have any significant advantages in
terms of hostital stay or 13ostoperative recovery.
Laparoscopic cholecystectomy serves as the
prototype success story for the introduction of
minimally invasive surgery into the mainstream
practice of surgery world wide. This study by
Majeed et al. recruited 200 patients over a three
and one-half year period with symptomatic
gallstones. Patients were randomized intra-
operatively after the induction of anesthesia to
undergo either standard laparoscopic cholecys-
tectomy with an attempt at routine operative
cholangiography, or "small-incision" cholecys-
tectomy. The small incision used in this study
was a high transverse sub-xiphoid incision,
dividing the rectus muscle as needed, and
dissecting the gallbladder from Calot’s triangle
toward the fundus with long instruments,
avoiding the insertion of hands into the
peritoneal cavity. An important aspect of this
study is that the patients were treated post-
operatively with a patient-controlled analgesic
system delivering morphine, and that the
patients were "told that they could get out of
bed and go home as soon as they felt fit